Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial

This publication has 31 references indexed in Scilit:

• Olanzapine and haloperidol in first episode psychosis: Two-year data
  Schizophrenia Research, 2006
• Linking the PANSS, BPRS, and CGI: Clinical Implications
  Neuropsychopharmacology, 2006
• Clinical trials for antipsychotic drugs: design conventions, dilemmas and innovations
  Nature Reviews Drug Discovery, 2006
• The European First Episode Schizophrenia Trial (EUFEST): Rationale and design of the trial
  Schizophrenia Research, 2005
• Risperidone and Haloperidol in First-Episode Psychosis: A Long-Term Randomized Trial
  American Journal of Psychiatry, 2005
• Comparative Efficacy and Safety of Atypical and Conventional Antipsychotic Drugs in First-Episode Psychosis: A Randomized, Double-Blind Trial of Olanzapine Versus Haloperidol
  American Journal of Psychiatry, 2003
• Relationship Between Dopamine D₂ Occupancy, Clinical Response, and Side Effects: A Double-Blind PET Study of First-Episode Schizophrenia
  American Journal of Psychiatry, 2000
• Multilevel time series models with applications to repeated measures data
  Statistics in Medicine, 1994
• The St. Hans Rating Scale for extrapyramidal syndromes: reliability and validity
  Acta Psychiatrica Scandinavica, 1993
• The UKU side effect rating scale: A new comprehensive rating scale for psychotropic drugs and a cross‐sectional study of side effects in neuroleptic‐treated patients
  Acta Psychiatrica Scandinavica, 1987